Gastric carcinoma: review of the results of treatment in a community teaching hospital
- PMID: 17659085
- PMCID: PMC1950881
- DOI: 10.1186/1477-7819-5-81
Gastric carcinoma: review of the results of treatment in a community teaching hospital
Abstract
Background: The aim of this study is to provide data on long term results of gastric cancer surgery and in particular the D1 gastric resection.
Methods: In the period 1992-2004, 235 male and female patients with a median age of 69 and 70 years respectively, were included with a stage I through IV gastric carcinoma, of which 37% was stage IV disease. Whenever possible a gastric resection was performed. In case of obstructive tumour growth palliation was provided by means of a gastro-enterostomy.
Results: Gastrectomy with curative intent was achieved in 50%, palliative resection in 22%, palliative surgery (gastro-enterostomy) in 10% and in 18% irresectability led to surgical exploration only. Patients in the curative intent group demonstrated a 47% survival after 5 years and up to 34% after 10 years. However metastases where seen in 32% of the patients after gastrectomy with curative intent. After palliative resection one year survival was 57%, whereas 19% survived more than 3 years. Overall postoperative morbidity and mortality rates were 40% and 13% respectively.
Conclusion: Long term survival after surgery for gastric cancer is poor and is improved by early detection and radical resection. However, palliative resection showed improved survival compared to gastro-enterostomy alone or no resection at all which may be an effect of adjuvant therapy.
Figures




Similar articles
-
Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?J Surg Oncol. 2007 Feb 1;95(2):118-22. doi: 10.1002/jso.20328. J Surg Oncol. 2007. PMID: 17262741
-
Total gastrectomy for gastric carcinoma.Hepatogastroenterology. 2005 Jan-Feb;52(61):302-4. Hepatogastroenterology. 2005. PMID: 15783055
-
The radical treatment of gastric carcinoma.Minerva Chir. 2004 Oct;59(5):471-7. Minerva Chir. 2004. PMID: 15494674
-
[Diagnosis of and therapy for gastric cancer--work-flow].Zentralbl Chir. 2009 Aug;134(4):362-74. doi: 10.1055/s-0029-1224534. Epub 2009 Aug 17. Zentralbl Chir. 2009. PMID: 19688686 Review. German.
-
[Long-term survival of patients with stomach cancer treated with subtotal gastrectomy].Rev Med Chil. 1993 Dec;121(12):1388-94. Rev Med Chil. 1993. PMID: 8085062 Review. Spanish.
Cited by
-
Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.PLoS One. 2015 Jun 29;10(6):e0130409. doi: 10.1371/journal.pone.0130409. eCollection 2015. PLoS One. 2015. PMID: 26121593 Free PMC article.
-
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center.Arch Med Sci. 2021 Dec 14;20(1):124-132. doi: 10.5114/aoms/141165. eCollection 2024. Arch Med Sci. 2021. PMID: 38414452 Free PMC article.
-
The role of non-curative surgery in incurable, asymptomatic advanced gastric cancer.PLoS One. 2013 Dec 16;8(12):e83921. doi: 10.1371/journal.pone.0083921. eCollection 2013. PLoS One. 2013. PMID: 24358318 Free PMC article.
-
Long-Term Survival of Gastric Adenocarcinoma without Therapy: Case Report.Oman Med J. 2010 Oct;25(4):303-5. doi: 10.5001/omj.2010.87. Oman Med J. 2010. PMID: 22043363 Free PMC article.
-
A systematic review of surgery for non-curative gastric cancer.Gastric Cancer. 2012 Sep;15 Suppl 1:S125-37. doi: 10.1007/s10120-011-0088-3. Epub 2011 Oct 28. Gastric Cancer. 2012. PMID: 22033891
References
-
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
-
- Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069–77. Epub 2004 Apr 13.. doi: 10.1200/JCO.2004.08.026. - DOI - PubMed
-
- Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767–73. Epub 2004 Jun 15.. doi: 10.1200/JCO.2004.10.184. - DOI - PubMed
-
- Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–1530. doi: 10.1038/sj.bjc.6690243. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases